Cholamandalam Securities experienced a significant downturn in Q4 and FY25, reporting a net loss of ₹0.47 crore in the latest quarter and an 88% decline in full-year profit. Sales also decreased substantially across both periods.
Sun Pharma, Incyte Settle Patent Case
Heat Wave Alert: IMD Update for Northwest India
OpenAI Teams Up with Google Cloud for AI Expansion
Tata Steel UK Begins Green Shift
Sobha Q1 FY26 Sales Rise 26% to Rs 1,717.2 Crore
CAMSPay Payment Gateway: Future-Proof Solutions for India's Dynamic Market
RBI Increases Gold Loan LTV Ratios
News that matters the most ⚡